title: Can blood gene expression predict which patients with multiple sclerosis will respond to interferon?
authors.affiliation: Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. kaminskin@upmc.edu
authors.forename: Naftali
authors.initials: N
authors.lastname: Kaminski
authors.forename: Anat
authors.initials: A
authors.lastname: Achiron
mesh_terms: D000276:Adjuvants, Immunologic / Q000494:pharmacology / Q000627:therapeutic use*; D020869:Gene Expression Profiling; D006801:Humans; D016899:Interferon-beta / Q000494:pharmacology / Q000627:therapeutic use*; D007963:Leukocytes, Mononuclear; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000235:genetics*; D010641:Phenotype; D016133:Polymerase Chain Reaction; D011237:Predictive Value of Tests; D011379:Prognosis; D016896:Treatment Outcome
chemical_list: D000276:Adjuvants, Immunologic; D016899:Interferon-beta
references.citation: Am J Respir Crit Care Med. 2004 Oct 15;170(8):911-9
references.pmid: 15215156
references.citation: Clin Exp Immunol. 2004 Oct;138(1):164-70
references.pmid: 15373920
references.citation: J Immunol. 1979 Oct;123(4):1615-8
references.pmid: 314466
references.citation: N Engl J Med. 1985 May 30;312(22):1405-11
references.pmid: 2985995
references.citation: Ann Neurol. 1999 Sep;46(3):425-8
references.pmid: 10482277
references.citation: PLoS Biol. 2005 Jan;3(1):e2
references.pmid: 15630474
references.citation: Mult Scler. 2002 Feb;8(1):19-23
references.pmid: 11936483
references.citation: Science. 2001 Nov 23;294(5547):1731-5
references.pmid: 11721059
references.citation: Nat Med. 2002 May;8(5):500-8
references.pmid: 11984595
references.citation: Brain. 2003 Jun;126(Pt 6):1419-29
references.pmid: 12764062
references.citation: Hum Mol Genet. 2003 Sep 1;12(17):2191-9
references.pmid: 12915464
references.citation: J Immunol. 2003 Sep 1;171(5):2694-702
references.pmid: 12928423
references.citation: Ann Neurol. 2004 Mar;55(3):410-7
references.pmid: 14991819
references.citation: Br J Cancer. 2004 Mar 22;90(6):1120-4
references.pmid: 15026788
references.citation: J Clin Invest. 2004 Mar;113(6):788-94
references.pmid: 15067307
references.citation: Lancet Neurol. 2004 May;3(5):269
references.pmid: 15099539
references.citation: Expert Opin Pharmacother. 2004 Apr;5(4):875-91
references.pmid: 15102570
references.citation: Chest. 2004 May;125(5 Suppl):111S-5S
references.pmid: 15136452
references.citation: Can J Neurol Sci. 2004 May;31(2):157-68
references.pmid: 15198439
references.citation: J Neurol. 2004 Jun;251 Suppl 2:II10-4
references.pmid: 15264107
references.citation: Curr Opin Oncol. 2004 Sep;16(5):436-41
references.pmid: 15314511
references.citation: J Immunol. 1978 Apr;120(4):1369-71
references.pmid: 305941